Elagolix Completed Phase 2 Trials for Endometriosis, Pain / Endometriosis / Pain NOS Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00437658Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis
NCT00973973Efficacy and Safety Study of Elagolix in Women With Endometriosis
NCT00797225Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis
NCT00619866An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis